Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaume Capdevila

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase I first-in-human pharmacokinetic and pharmacodynamic study of serdemetan in patients with advanced solid tumorsJosep Tabernero, Luc Dirix, Patrick Schöffski, et al.
The Oncologist|May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR StudyJaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
The Oncologist|April 10, 2019
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell CarcinomaRocio Garcia-Carbonero, Ivan Marquez-Rodas, Luis de la Cruz-Merino, et al.
Journal of Neuroendocrinology|April 6, 2026
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoidsEric Baudin, Alice Durand, Wieneke Buikhuisen, et al.
World Journal of Hepatology|June 16, 2021
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case reportOriol Mirallas, Nadia Saoudi, Diego Gómez-Puerto, et al.
Health and Quality of Life Outcomes|January 31, 2021
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Marta Benavent, Javier Sastre, Ignacio García Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2023
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)Jaume Capdevila Castillón, Teresa Alonso Gordoa, Alberto Carmona Bayonas, et al.
World Journal of Gastroenterology|June 1, 2022
Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomyJosé Luis Muñoz de Nova, Jorge Hernando, Miguel Sampedro Núñez, et al.
Thyroid : Official Journal of the American Thyroid Association|February 27, 2021
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with LenvatinibMatthew H Taylor, Shunji Takahashi, Jaume Capdevila, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|March 4, 2015
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)Juan C Galofré, Javier Santamaría Sandi, Jaume Capdevila, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2011
A phase I first-in-human pharmacokinetic and pharmacodynamic study of serdemetan in patients with advanced solid tumorsJosep Tabernero, Luc Dirix, Patrick Schöffski, et al.
The Oncologist|May 26, 2018
Phase II Study of Everolimus and Octreotide LAR in Patients with Nonfunctioning Gastrointestinal Neuroendocrine Tumors: The GETNE1003_EVERLAR StudyJaume Capdevila, Alexandre Teulé, Jorge Barriuso, et al.
The Oncologist|April 10, 2019
Recent Therapeutic Advances and Change in Treatment Paradigm of Patients with Merkel Cell CarcinomaRocio Garcia-Carbonero, Ivan Marquez-Rodas, Luis de la Cruz-Merino, et al.
Journal of Neuroendocrinology|April 6, 2026
European Society of Neuroendocrine Tumors (ENETS) 2025 guidance paper for lung and thymic carcinoidsEric Baudin, Alice Durand, Wieneke Buikhuisen, et al.
World Journal of Hepatology|June 16, 2021
Acquired hepatocerebral degeneration in a metastatic neuroendocrine tumor long-term survivor - an update on neuroendocrine neoplasm's treatment: A case reportOriol Mirallas, Nadia Saoudi, Diego Gómez-Puerto, et al.
Health and Quality of Life Outcomes|January 31, 2021
Physician-perceived utility of the EORTC QLQ-GINET21 questionnaire in the treatment of patients with gastrointestinal neuroendocrine tumours: a multicentre, cross-sectional survey (QUALINETS)Marta Benavent, Javier Sastre, Ignacio García Escobar, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 19, 2023
SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)Jaume Capdevila Castillón, Teresa Alonso Gordoa, Alberto Carmona Bayonas, et al.
World Journal of Gastroenterology|June 1, 2022
Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomyJosé Luis Muñoz de Nova, Jorge Hernando, Miguel Sampedro Núñez, et al.
Thyroid : Official Journal of the American Thyroid Association|February 27, 2021
Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with LenvatinibMatthew H Taylor, Shunji Takahashi, Jaume Capdevila, et al.
Endocrinologia Y Nutricion : Organo De La Sociedad Espanola De Endocrinologia Y Nutricion|March 4, 2015
Consensus on the management of advanced medullary thyroid carcinoma on behalf of the Working Group of Thyroid Cancer of the Spanish Society of Endocrinology (SEEN) and the Spanish Task Force Group for Orphan and Infrequent Tumors (GETHI)Juan C Galofré, Javier Santamaría Sandi, Jaume Capdevila, et al.
Pageof 20